The regulation of mefv expression and its role in health and familial mediterranean fever

The regulation of mefv expression and its role in health and familial mediterranean fever

Play all audios:

Loading...

ABSTRACT Familial Mediterranean fever (FMF) is a hereditary recurrent fever associated with mutations in the gene _MEFV_ encoding pyrin. It is expressed mainly in neutrophils and


macrophages, and modulates the production of the potent pro-inflammatory cytokine interleukin-1β through regulation of nuclear factor-κB and caspase-1. The _MEFV_ gene expression depends on


multiple levels of regulation. Sequence variants located in the promoter and at the 3′-untranslated region of the gene modulate this expression. Two studies demonstrated decreased mRNA


levels in FMF patients compared with healthy subjects, whereas two others found no significant differences. The diverse experimental settings may have resulted in variable quantification of


the 15 splice variants that have been identified recently. Some of these isoforms are regulated by nonsense-mediated decay in both cell- and transcript-specific manner, and may be


differentially translated in THP1 cells. In addition, pyrin may be cleaved by caspase 1. The full-length pyrin was less abundant than the cleaved fragment in mononuclear cells from FMF


patients than in controls, whereas the opposite was observed in granulocytes. Altogether, the regulation of _MEFV_ expression is more complex than anticipated in both physiological and


pathological conditions. Its deregulation is likely to alter the inflammasome function and subsequently result in uncontrolled inflammation as seen in FMF. Access through your institution


Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 6 digital issues and


online access to articles $119.00 per year only $19.83 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to


local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT


BEING VIEWED BY OTHERS MUTATIONS IN THE B30.2 AND THE CENTRAL HELICAL SCAFFOLD DOMAINS OF PYRIN DIFFERENTIALLY AFFECT INFLAMMASOME ACTIVATION Article Open access 25 March 2023 FAMILIAL


MEDITERRANEAN FEVER-RELATED MIR-197-3P TARGETS _IL1R1_ GENE AND MODULATES INFLAMMATION IN MONOCYTES AND SYNOVIAL FIBROBLASTS Article Open access 12 January 2021 THE PAST 25 YEARS IN


PAEDIATRIC RHEUMATOLOGY: INSIGHTS FROM MONOGENIC DISEASES Article 07 August 2024 REFERENCES * Heller H, Kariv J, Sherf L, Sohar E . Familial Mediterranean fever]. _Harefuah_ 1955; 48 (5):


91–94. CAS  PubMed  Google Scholar  * The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever.


_Cell_ 1997; 90: 797–807. Article  Google Scholar  * The French FMF Consortium. A candidate gene for familial Mediterranean fever. _Nat Genet_ 1997; 17: 25–31. Article  Google Scholar  *


Martinon F, Hofmann K, Tschopp J . The pyrin domain: a possible member of the death domain-fold family implicated in apoptosis and inflammation. _Curr Biol_ 2001; 11: R118–R120. Article  CAS


  Google Scholar  * Pawlowski K, Pio F, Chu Z, Reed JC, Godzik A . PAAD - a new protein domain associated with apoptosis, cancer and autoimmune diseases. _Trends Biochem Sci_ 2001; 26:


85–87. Article  CAS  Google Scholar  * Staub E, Dahl E, Rosenthal A . The DAPIN family: a novel domain links apoptotic and interferon response proteins. _Trends Biochem Sci_ 2001; 26: 83–85.


Article  CAS  Google Scholar  * Kohl A, Grutter MG . Fire and death: the pyrin domain joins the death-domain superfamily. _C R Biol_ 2004; 327: 1077–1086. Article  CAS  Google Scholar  *


Stehlik C, Fiorentino L, Dorfleutner A, Bruey JM, Ariza EM, Sagara J _et al_. The PAAD/PYRIN-family protein ASC is a dual regulator of a conserved step in nuclear factor kappaB activation


pathways. _J Exp Med_ 2002; 196: 1605–1615. Article  CAS  Google Scholar  * Dowds TA, Masumoto J, Chen FF, Ogura Y, Inohara N, Nunez G . Regulation of cryopyrin/Pypaf1 signaling by pyrin,


the familial Mediterranean fever gene product. _Biochem Biophys Res Commun_ 2003; 302: 575–580. Article  CAS  Google Scholar  * Masumoto J, Dowds TA, Schaner P, Chen FF, Ogura Y, Li M _et


al_. ASC is an activating adaptor for NF-kappaB and caspase-8-dependent apoptosis. _Biochem Biophys Res Commun_ 2003; 303: 69–73. Article  CAS  Google Scholar  * Chae JJ, Wood G, Richard K,


Jaffe H, Colburn NT, Masters SL _et al_. The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment. _Blood_ 2008; 112:


1794–1803. Article  CAS  Google Scholar  * Yu JW, Wu J, Zhang Z, Datta P, Ibrahimi I, Taniguchi S _et al_. Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization.


_Cell Death Differ_ 2006; 13: 236–249. Article  CAS  Google Scholar  * Chae JJ, Wood G, Masters SL, Richard K, Park G, Smith BJ _et al_. The B30.2 domain of pyrin, the familial


Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. _Proc Natl Acad Sci USA_ 2006; 103: 9982–9987. Article  CAS  Google Scholar  * Papin S, Cuenin


S, Agostini L, Martinon F, Werner S, Beer HD _et al_. The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits


proIL-1beta processing. _Cell Death Differ_ 2007; 14: 1457–1466. Article  CAS  Google Scholar  * Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L _et al_. The tripartite motif


family identifies cell compartments. _EMBO J_ 2001; 20: 2140–2151. Article  CAS  Google Scholar  * Milhavet F, Cuisset L, Hoffman HM, Slim R, El-Shanti H, Aksentijevich I _et al_. The


infevers autoinflammatory mutation online registry: update with new genes and functions. _Hum Mutat_ 2008; 29: 803–808. Article  Google Scholar  * Ben-Chetrit E, Levy M . Familial


Mediterranean fever. _Lancet_ 1998; 351: 659–664. Article  CAS  Google Scholar  * Chae JJ, Aksentijevich I, Kastner DL . Advances in the understanding of familial Mediterranean fever and


possibilities for targeted therapy. _Br J Haematol_ 2009; 146: 467–478. Article  CAS  Google Scholar  * Schroder K, Tschopp J . The inflammasomes. _Cell_ 2010; 140: 821–832. Article  CAS 


Google Scholar  * Centola M, Wood G, Frucht DM, Galon J, Aringer M, Farrell C _et al_. The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is


regulated in response to inflammatory mediators. _Blood_ 2000; 95: 3223–3231. CAS  PubMed  Google Scholar  * Tidow N, Chen X, Muller C, Kawano S, Gombart AF, Fischel-Ghodsian N _et al_.


Hematopoietic-specific expression of MEFV, the gene mutated in familial Mediterranean fever, and subcellular localization of its corresponding protein, pyrin. _Blood_ 2000; 95: 1451–1455.


CAS  PubMed  Google Scholar  * Diaz A, Hu C, Kastner DL, Schaner P, Reginato AM, Richards N _et al_. Lipopolysaccharide-induced expression of multiple alternatively spliced MEFV transcripts


in human synovial fibroblasts: a prominent splice isoform lacks the C-terminal domain that is highly mutated in familial Mediterranean fever. _Arthritis Rheum_ 2004; 50: 3679–3689. Article 


CAS  Google Scholar  * Papin S, Cazeneuve C, Duquesnoy P, Jeru I, Sahali D, Amselem S . The tumor necrosis factor alpha-dependent activation of the human mediterranean fever (MEFV) promoter


is mediated by a synergistic interaction between C/EBP beta and NF kappaB p65. _J Biol Chem_ 2003; 278: 48839–48847. Article  CAS  Google Scholar  * Notarnicola C, Boizet-Bonhoure B, de


Santa Barbara P, Osta MA, Cattan D, Touitou I . Characterization of new mutations in the 5′-flanking region of the familial Mediterranean fever gene. _Genes Immun_ 2009; 10: 273–279. Article


  CAS  Google Scholar  * Ustek D, Ekmekci C, Oku B, Cosan F, Cakiris A, Abaci N _et al_. MEFV gene 3′-UTR Alu repeat polymorphisms in patients with familial Mediterranean fever. _Clin Exp


Rheumatol_ 2008; 26 (4 Suppl 50): S72–S76. CAS  PubMed  Google Scholar  * Papin S, Duquesnoy P, Cazeneuve C, Pantel J, Coppey-Moisan M, Dargemont C _et al_. Alternative splicing at the MEFV


locus involved in familial Mediterranean fever regulates translocation of the marenostrin/pyrin protein to the nucleus. _Hum Mol Genet_ 2000; 9: 3001–3009. Article  CAS  Google Scholar  *


Grandemange S, Soler S, Touitou I . Expression of the familial Mediterranean fever gene is regulated by nonsense-mediated decay. _Hum Mol Genet_ 2009; 18: 4746–4755. Article  CAS  Google


Scholar  * Medlej-Hashim M, Nehme N, Chouery E, Jalkh N, Megarbane A . Novel MEFV transcripts in familial Mediterranean fever patients and controls. _BMC Med Genet_ 2010; 11: 87. Article 


Google Scholar  * Neu-Yilik G, Kulozik AE . NMD: multitasking between mRNA surveillance and modulation of gene expression. _Adv Genet_ 2008; 62: 185–243. Article  CAS  Google Scholar  *


Linde L, Boelz S, Nissim-Rafinia M, Oren YS, Wilschanski M, Yaacov Y _et al_. Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients


to gentamicin. _J Clin Invest_ 2007; 117: 683–692. Article  CAS  Google Scholar  * Notarnicola C, Didelot MN, Kone-Paut I, Seguret F, Demaille J, Touitou I . Reduced MEFV messenger RNA


expression in patients with familial Mediterranean fever. _Arthritis Rheum_ 2002; 46: 2785–2793. Article  CAS  Google Scholar  * Ustek D, Ekmekci CG, Selcukbiricik F, Cakiris A, Oku B, Vural


B _et al_. Association between reduced levels of MEFV messenger RNA in peripheral blood leukocytes and acute inflammation. _Arthritis Rheum_ 2007; 56: 345–350. Article  CAS  Google Scholar


  * Mitroulis I, Kourtzelis I, Kambas K, Chrysanthopoulou A, Ritis K . Evidence for the involvement of mTOR inhibition and basal autophagy in familial Mediterranean fever phenotype. _Hum


Immunol_ 2010; 72: 135–138. Article  Google Scholar  * Booty MG, Chae JJ, Masters SL, Remmers EF, Barham B, Le JM _et al_. Familial Mediterranean fever with a single MEFV mutation: where is


the second hit? _Arthritis Rheum_ 2009; 60: 1851–1861. Article  CAS  Google Scholar  * Cazeneuve C, Papin S, Jeru I, Duquesnoy P, Amselem S . Subcellular localisation of marenostrin/pyrin


isoforms carrying the most common mutations involved in familial Mediterranean fever in the presence or absence of its binding partner ASC. _J Med Genet_ 2004; 41: e24. Article  CAS  Google


Scholar  * Jeru I, Papin S, L'Hoste S, Duquesnoy P, Cazeneuve C, Camonis J _et al_. Interaction of pyrin with 14.3.3 in an isoform-specific and phosphorylation-dependent manner


regulates its translocation to the nucleus. _Arthritis Rheum_ 2005; 52: 1848–1857. Article  CAS  Google Scholar  * Abedat S, Urieli-Shoval S, Shapira E, Calko S, Ben-Chetrit E, Matzner Y .


Effect of colchicine and cytokines on MEFV expression and C5a inhibitor activity in human primary fibroblast cultures. _Isr Med Assoc J_ 2002; 4: 7–12. CAS  PubMed  Google Scholar  * Matzner


Y, Abedat S, Shapiro E, Eisenberg S, Bar-Gil-Shitrit A, Stepensky P _et al_. Expression of the familial Mediterranean fever gene and activity of the C5a inhibitor in human primary


fibroblast cultures. _Blood_ 2000; 96: 727–731. CAS  PubMed  Google Scholar  * Masters SL, Yao S, Willson TA, Zhang JG, Palmer KR, Smith BJ _et al_. The SPRY domain of SSB-2 adopts a novel


fold that presents conserved Par-4-binding residues. _Nat Struct Mol Biol_ 2006; 13: 77–84. Article  CAS  Google Scholar  Download references ACKNOWLEDGEMENTS This work was supported by the


CHRU of Montpellier (PHRC2005), the National Human Genome Research Institute, INSERM and Istanbul Faculty of Medicine. We thank the clinicians for providing patient samples, J Tazy for


helpful discussion and M Vittal for English editing of the manuscript. AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Unité médicale des maladies auto-inflammatoires, CHRU de Montpellier,


INSERM U844, UM1, Hopital Arnaud de Villeneuve, Montpellier, France S Grandemange & I Touitou * National Human Genome Research Institute, Bethesda, MD, USA I Aksentijevich * INSERM U933,


Université Pierre et Marie Curie-Paris6 UMR S933, Paris, France I Jeru * Division of Rheumatology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University,


Istanbul, Turkey A Gul Authors * S Grandemange View author publications You can also search for this author inPubMed Google Scholar * I Aksentijevich View author publications You can also


search for this author inPubMed Google Scholar * I Jeru View author publications You can also search for this author inPubMed Google Scholar * A Gul View author publications You can also


search for this author inPubMed Google Scholar * I Touitou View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to I


Touitou. ETHICS DECLARATIONS COMPETING INTERESTS The authors declare no conflict of interest RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Grandemange,


S., Aksentijevich, I., Jeru, I. _et al._ The regulation of MEFV expression and its role in health and familial Mediterranean fever. _Genes Immun_ 12, 497–503 (2011).


https://doi.org/10.1038/gene.2011.53 Download citation * Received: 20 May 2011 * Accepted: 27 June 2011 * Published: 21 July 2011 * Issue Date: October 2011 * DOI:


https://doi.org/10.1038/gene.2011.53 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not


currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative KEYWORDS * expression * _MEFV_ * FMF